CMS951v3: Kidney Health Evaluation

Percentage of patients aged 18-85 years with a diagnosis of diabetes who received a kidney health evaluation defined by an Estimated Glomerular Filtration Rate (eGFR) AND Urine Albumin-Creatine Ratio (uACR) within the measurement period.

Numerator

Patients who received a kidney health evaluation defined by an eGFR and a uACR within the measurement period

Results must be entered into Amazing Charts in one of the following ways:

  • Electronic Result: Imported from HL7 Lab Interface. Results must be named "eGFR" and "uACR"
  • Tracked Data: Entered into Tracked Data on the Summary Sheet
    • From the patient’s chart, select “Summary Sheet” tab at the top of the chart
    • The “Tracked Data” section will be on the right of the page. Click “Add/Edit”
    • Enter "eGFR" into the Item
    • Enter the Value
    • Enter the date collected
    • Select “Move Data To Grid” and then click “Ok”
    • Enter "uACR" into the Item
    • Enter the Value
    • Enter the date collected
    • Select “Move Data To Grid” and then click “Ok”
    • Select “Save and Close”

Note: BOTH results need to be entered for the measure to count.

Denominator

All patients aged 18-85 years with a diagnosis of diabetes at the start of the measurement period, with a visit during the measurement period

In order for patients to qualify for the measure, they must:

  • Age between 18-85
  • Has an active diagnosis of diabetes at the start of the measurement period (new diagnosis of diabetes made during the measurement period will not count)
  • One eligible visit during the measurement period
    • This must be an office visit CPT entered into Amazing Charts during sign off

Exclusions:

  • Exclude patients whose hospice or palliative care overlaps the measurement period:
    • Identified in the patient's Alerts and Directives, located in the demographic screen or the Summary Sheet, in the name, text or comments saved with that alert/directive. The Alert/Directive should include either of the following phrases:
      • palliative
      • hospice
  • Exclude patients with a diagnosis of End Stage Renal Disease active during the measurement period
  • Exclude patients with a diagnosis of Chronic Kidney Disease, Stage 5 active during the measurement period